About Rencord Life Sciences Private Limited
Data last updated:
Rencord Life Sciences Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 10 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2011PTC043919. Its GSTIN is 09AAECC3692D1ZO (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.2 Lakh. It was formerly known as Concord Medipharma Private Limited. It is led by directors including Satyajit Singh and Tushar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 256 Express Road Kanpur Nagar Kanpur, Uttar Pradesh, India – 208001.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.09 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.32 Cr (net margin 7.7%) and EBITDA of ₹1.88 Cr (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 26% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Rencord Life Sciences.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rencord.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No – 256 Express Road Kanpur Nagar Kanpur, Uttar Pradesh, India – 208001
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Rencord Life Sciences Private Limited
Rencord Life Sciences operates one associated brand: Rencord Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of pharmaceutical products and services in the healthcare sector. | rencord.com |
Business Activity of Rencord Life Sciences Private Limited
The main business activity of Rencord Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rencord Life Sciences Private Limited FY 2025 filings available
Rencord Life Sciences Private Limited reported revenue of ₹17.09 Cr (up 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Rencord Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 36% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rencord Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.88 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.32 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rencord Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 7.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rencord Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rencord Life Sciences Private Limited
Rencord Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyajit Singh | Director | 11 Aug 2013 | 13 Years 2 Months | Current |
| Tushar Gupta | Director | 21 Jan 2013 | 13 Years 9 Months | Current |
| Abhishek Kumar Trivedi | Director | 21 Jan 2013 | 13 Years 9 Months | Current |
Peer Comparison of Rencord Life Sciences Private Limited
Rencord Life Sciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shri Ram Krishana Healthcare Private Limited | ₹17.37 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Jaipur, Rajasthan, India |
| Govind Life Cure Private Limited | ₹17.35 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Proscan Diagnostics Private Limited | ₹17.21 Cr (FY 2020) | •••• | •••• | 0.0% | •••• | Chennai, Tamil Nadu, India |
| Sunrise Global Superspeciality Hospital and Rehabilitation Institute Private Limited | ₹17.15 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Nanded, Maharashtra, India |
| Winning Healthcare Private Limited | ₹17.12 Cr (FY 2025) | •••• | •••• | 91.0% | •••• | Jaipur, Rajasthan, India |
| Rencord Life Sciences Private Limited this company | ₹17.09 Cr (FY 2024) | •••• | •••• | 36.0% | •••• | Kanpur, Uttar Pradesh, India |
| Ashish Joint Replacement Care Private Limited | ₹17.07 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Patna, Bihar, India |
| Lexington Healthcare Private Limited | ₹17.03 Cr (FY 2025) | •••• | •••• | 121.0% | •••• | Bangalore, Karnataka, India |
| Mumbai Citiclinic Private Limited | ₹16.98 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Mumbai, Maharashtra, India |
| Anukar Health Care Private Limited | ₹16.96 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Advanced Institute of Liver and Biliary Sciences Private Limited | ₹16.83 Cr (FY 2025) | •••• | •••• | -48.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Rencord Life Sciences by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rencord Life Sciences Private Limited
Rencord Life Sciences Private Limited is audited by R KAPOOR & ASSOCIATES for the financial year 2018.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R KAPOOR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rencord Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rencord Life Sciences Private Limited
Rencord Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rencord Life Sciences Private Limited
Rencord Life Sciences Private Limited has a workforce of 33 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rencord Life Sciences Private Limited
Rencord Life Sciences Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Anurag Tripathi ceased to be Director on 15 Apr 2015.
Credit Ratings, Litigation & Regulatory Alerts for Rencord Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rencord Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rencord Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rencord Life Sciences Private Limited
Rencord Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECC3692D1ZO | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rencord Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rencord Life Sciences Private Limited
Rencord Life Sciences is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 10 March 2011 (15+ years old) and is registered under CIN U85191UP2011PTC043919.
Rencord Life Sciences reported revenue of ₹17.09 Cr for FY 2024 (up 36% YoY).
Rencord Life Sciences has 3 current directors:
- Satyajit Singh - Director
- Tushar Gupta - Director
- Abhishek Kumar Trivedi - Director
Rencord Life Sciences reported a net profit of ₹1.32 Cr (net margin 7.7%) and EBITDA of ₹1.88 Cr (EBITDA margin 11%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rencord Life Sciences is 23% over three years and 26% over five years. In the latest year (FY 2024) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rencord Life Sciences is 09AAECC3692D1ZO, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Rencord Life Sciences is U85191UP2011PTC043919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rencord Life Sciences was incorporated on 10 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Rencord Life Sciences by revenue are Shri Ram Krishana Healthcare Private Limited, Govind Life Cure Private Limited, Proscan Diagnostics Private Limited, Sunrise Global Superspeciality Hospital and Rehabilitation Institute Private Limited, Winning Healthcare Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Anurag Tripathi ceased to be Director on 15 Apr 2015. Abhishek Kumar Trivedi ceased to be Additional Director on 09 Dec 2013. Tushar Gupta ceased to be Additional Director on 30 Sep 2013. Rencord Life Sciences has 7 board changes on record in total.
Rencord Life Sciences can be reached through the website rencord.com. Its registered office is in Kanpur, Uttar Pradesh, India.